L-arginine as an adjuvant drug in the treatment of sickle cell anaemia

British Journal of Haematology

Volumn 160, Issue 3, 2013, Pages 410-412

  Elias, Darcielle Bruna Dias ^a   Barbosa, Maritza Cavalcante ^a   Rocha, Lilianne Brito da Silva ^a   Dutra, Luana Letícia Alves ^a   Silva, Herivaldo Ferreira da ^b   Martins, Alice Maria Costa ^a   Gonçalves, Romélia Pinheiro ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Blood Centre of the State of Ceará   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HEMOGLOBIN F; HYDREIA; HYDROXYUREA; NITRITE; REFORGAN; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AMINO ACID ANALYSIS; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG POTENTIATION; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; UNIVERSITY HOSPITAL;

ADJUVANTS, PHARMACEUTIC; ANEMIA, SICKLE CELL; ARGININE; ERYTHROCYTE INDICES; HUMANS; NITRITES; OXIDATIVE STRESS;

EID: 84872619821     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12114     Document Type: Letter

References (10)

1. Baliga, B.S., Haynes, Jr, J., Obiako, B. & Mishra, N. (2010) Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesisin erythroid progenitors isolated from sickle cell blood. Cellular and molecular biology, Jun 156(Suppl:OL1290-8), 1290-1298.
2. Cokic, V.P., Andric, S.A., Stojilkovic, S.S., Noguchi, C.T. & Schechter, A.N. (2008) Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood, 111(3), 1117-1123.
3. Dasgupta, T., Hebbel, R.P. & Kaul, D.K. (2006) Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radic Biol Med, 41, 1771-1780.
4. Kato, G.J., Gladwin, M.T. & Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood, 21, 37-47.
5. Morris, C.R., Vichinsky, E.P., Warmerdam, J.V., Machado, L., Kepka-Lenhart, D., Morris, Jr, S.M. & Kuypers, F.A. (2003) Hydroxyurea and Arginine Therapy: impact on nitric oxide production in sickle cell disease. Journal of Pediatric Hematology/Oncology, 25, 629-633.
6. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr, S.M.. & Gladwin, M.T. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. The Journal of the American Medical Association, 294, 81-90.
7. Morris, C.R., Gladwin, M.T. & Kato, G.J. (2008) Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Current Molecular Medicine, 7, 620-632.
8. Nahavandi, M., Perlin, E., Kassimm, O., Wyche, M.Q., Castro, O. & Tavakkoli, F. (2000) Upregulation of TNF-alpha by hydroxyurea in patients with sickle cell anemia. Blood, 96(suppl.1), 44.
9. Strouse, J.J., Lanzkorn, S., Beach, M.C., Haywood, C., Park, H., Witkop, C., Wilson, R.F., Bass, E.B., & Segal, J.B. (2008) Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics, 122, 1332-1342.
10. Sullivan, K.J., Kissoon, N., Sandler, E., Gauger, C., Froyen, M., Duckworth, L., Brown, M. & Murphy, S. (2010) Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome. Journal of Pediatric Hematology/oncology, 32, 249-258.